Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study
CONCLUSION: Although VE against hospitalization was 78% and increased to 89% after boosting during the Delta-dominant study period, VE was lower in certain high risk groups, for which indirect protection or other protective measures might be of added importance.PMID:38688804 | DOI:10.1016/j.vaccine.2024.04.017
Source: Vaccine - Category: Allergy & Immunology Authors: F A Niessen P C J L Bruijning-Verhagen M J M Bonten VECTOR study group M J Knol Source Type: research
More News: Allergy & Immunology | Cancer & Oncology | Covid Vaccine | COVID-19 | Netherlands Health | Nurses | Nursing | Residencies | Respiratory Medicine | SARS | Study | Vaccines